tyramine has been researched along with probenecid in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (57.14) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Bunney, W; Gillin, JC; Jimerson, D; Karoum, F; Van Kammen, D; Wyatt, RJ | 1 |
| Bläsig, J; Gramsch, C; Herz, A | 1 |
| Quebbemann, AJ; Rennick, BR | 1 |
| Deiman-Van Aalst, WM; Eigeman, L; Vaatstra, WJ | 1 |
| Egelund, J; Gliemann, L; Hellsten, Y; Isakson, BE; Jørgensen, TS; Kiehn, OT; Maagaard, C; Nielsen, MS; Nyberg, M; Piil, P | 1 |
1 review(s) available for tyramine and probenecid
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
6 other study(ies) available for tyramine and probenecid
| Article | Year |
|---|---|
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Effect of probenecid on the concentration of the lumbar cerebrospinal fluid acidic metabolites of tyramine, octopamine, dopamine and norepinephrine.
Topics: Dopamine; Female; Gas Chromatography-Mass Spectrometry; Homovanillic Acid; Humans; Male; Norepinephrine; Octopamine; Probenecid; Schizophrenia; Tyramine | 1977 |
Changes in striatal dopamine metabolism during precipitated morphine withdrawal.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Benzomorphans; Catechol O-Methyltransferase; Corpus Striatum; Dopamine; Homovanillic Acid; Humans; Male; Monoamine Oxidase; Morphine; Naloxone; Probenecid; Rats; Substance Withdrawal Syndrome; Time Factors; Tyramine | 1977 |
Effects of structural modifications of catecholamines on renal tubular transport in the chicken.
Topics: Aminohippuric Acids; Animals; Biological Transport; Carbon Isotopes; Catecholamines; Chickens; Dopamine; Epinephrine; Ethylamines; Isoproterenol; Kidney Tubules; Norepinephrine; Octopamine; Phenethylamines; Probenecid; Quinine; Tetraethylammonium Compounds; Tritium; Tyramine | 1969 |
Du 24565, a quipazine derivative, a potent selective serotonin uptake inhibitor.
Topics: 5-Hydroxytryptophan; Animals; Antidepressive Agents; Blood Platelets; In Vitro Techniques; Male; Mice; p-Chloroamphetamine; Probenecid; Quinolines; Quipazine; Rabbits; Rats; Serotonin; Serotonin Antagonists; Synaptosomes; Tyramine | 1981 |
Probenecid Inhibits α-Adrenergic Receptor-Mediated Vasoconstriction in the Human Leg Vasculature.
Topics: Adrenergic Uptake Inhibitors; Adult; Arteries; Blood Pressure; Connexins; Extremities; Humans; Male; Muscle, Smooth, Vascular; Nerve Tissue Proteins; Probenecid; Receptors, Adrenergic; Regional Blood Flow; Sympathetic Nervous System; Tyramine; Vascular Resistance; Vasoconstriction; Vasoconstrictor Agents | 2018 |